Opioids Market Size, Share 2019 Opioids Drug Industry Analysis, Leading Growth Drivers, Emerging Audience, Industry Segments, Sales, Profits and Regional Study by 2023

Opioids Market Size, Share 2019 Opioids Drug Industry Analysis, Leading Growth Drivers, Emerging Audience, Industry Segments, Sales, Profits and Regional Study by 2023

“Opioids Market Analysis”
Market Research Future (MRFR) publishes a periodic market research report on Opioids Market Information: By Product (Extended-Release/Long-Acting Opioid, Immediate Release/Short-Acting Opioid), By Application (Pain Relief, Anesthesia, Cough Suppression, Deaddiction, Others), By End User, and by Region — Global Forecast till 2023

Leading Market Players

 Sanofi SA (France), Pfizer Inc. (US), Boehringer Ingelheim GmbH (Germany), Teva Pharmaceutical Industries Ltd (Israel), Allergan Inc. (US), Purdue Pharma L.P. (US), West-Ward Pharmaceuticals Corporation (Jordan), Sun Pharmaceutical Industries Ltd (India), Egalet Corporation (US), Janssen Global Services, LLC (US), Vertice Pharma LLC (UK), Mallinckrodt (Surrey), and others.

 

PICK UP THE FREE SAMPLE COPY @ https://www.marketresearchfuture.com/sample_request/7626

 Opioids Market Overview

The global opioids market is expected to register a CAGR of 7.12% during the forecast period with a market value of USD 19,554.49 million in 2017. Opioids are a type of narcotic pain medications that are used to treat moderate to severe pain medications. According to the National Health Interview Survey 2017, 25.3 million Americans suffer from chronic pain daily and 23.4 million people reported their pain as severe.

Segmentation Analysis

The global opioids market, by product, has been segmented into extended-release/long-acting opioids and immediate-release/short-acting opioids. The extended-release opioid segment is further segmented into oxycodone, oxymorphone, morphine, hydromorphone, and others. The extended-release opioid segment accounted for a value of USD 12,750.91 million in 2017. The immediate-release opioid segment is further segmented into codeine, hydrocodone, fentanyl, morphine, and others. The market, by application, can be segmented into pain relief, anesthesia, cough suppression, diarrhea suppression, and de-addiction. On the basis of end user, the global opioids market is segmented into hospitals & clinics, pharmacies, and academic research institutes.

Table of Content

4  Market Dynamics

4.1 Introduction

4.2 Drivers

4.2.1 Increasing Use Of Opioids For Disease Condition Causing Chronic Pains Such As Cancers, Arthritis, Lower Back Pain, And Fibromyalgia

4.2.2 Favorable Reimbursement Policies For Palliative Care In Developed Regions

4.2.3 Substantial Rise In Road Accidents, Trauma, And Surgical Procedures

4.3 Restraints

4.3.1 Rising Addiction And Death Cases Due To Overdose Of Opioid 26

4.4 Opportunities

4.4.1 Reconsideration Of Prescribing Opioid Analgesics Due To Rising Awareness About Opioids Misuse, Abuse, And Overdose Has Prompted Many Stakeholders

  List of Tables

TABLE 1 MARKET SYNOPSIS

TABLE 2 PRIMARY INTERVIEWS

TABLE 3 GLOBAL OPIOIDS MARKET, BY PRODUCT, 2015–2023 (USD MILLION)

TABLE 4 GLOBAL OPIOIDS MARKET FOR EXTENDED-RELEASE OPIOID, BY REGION, 2015–2023 (USD MILLION)

TABLE 5 GLOBAL OPIOIDS MARKET FOR EXTENDED-RELEASE OPIOID, BY TYPE, 2015–2023 (USD MILLION)

Continued…

COLLECT DETAILED INFORMATION OF THE REPORT @ https://www.marketresearchfuture.com/reports/opioids-market-7626

Intended Audience

  • Pharmaceutical Companies
  • Research Institutes
  • Hospitals
  • Academic Institutes

This research report provides insights, on various levels of analysis such as industry analysis, market share analysis, leading market players, and their profiles. This report also helps in studying the target segments by providing views on emerging and high-growth segments and market conclusion. Together the market data comprises and discusses basic assessments on the competitive scenarios and strategies of the global opioids market.

New in Research

Opioid-induced constipation is on the rise due to being one of the side-effects during intake of pain relievers. In 2019, Novartis has agreed to partner with Shinogi & Co Ltd, for bringing to market Rizmoic in selected areas of the Netherlands, the U.K., and Germany.

According to a study published by the researchers at the University of Pennsylvania School of Medicine, patients in the United States and Canada are more likely to procure opioids due to the large number of chronic diseases. High prevalence of minimally invasive surgeries and prescription of codeine in post-operative care can bode well for the global opioids market in the coming years.

Related News

Myocardial Ischemia Market  – Global Forecast till 2023

Suture Needle Market  – Global Forecast till 2023

About Market Research Future:

MRFR team has supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country-level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with the technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:

Market Research Future

+1 646 845 9312

Email: sales@marketresearchfuture.com

Media Contact
Company Name: Market Research Future
Contact Person: Abhishek Sawant
Email: Send Email
Phone: +1 646 845 9312
Address:Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar
City: Pune
State: Maharashtra
Country: India
Website: https://www.marketresearchfuture.com/reports/opioids-market-7626